DalsnaFinance › IPOs › Black Diamond Therapeutics › IPO
Black Diamond Therapeutics, Inc. completed its initial public offering on NASDAQ on January 30, 2020, pricing at $19.00 a share.
| Ticker | BDTX |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | January 30, 2020 |
| Offering price | $19.00 |
| Shares offered | 10,586,316 |
| Total raised | $201M |
Black Diamond Therapeutics, Inc. sold 10,586,316 shares at $19.00 each on NASDAQ. Multiplied out, that is $201.1 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $201 million total recorded for the deal.
Black Diamond Therapeutics, Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Black Diamond Therapeutics, Inc.. This page is general information, not investment advice.